HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason T Olin Selected Research

Rivastigmine (Exelon)

4/2011Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses.
2/2011Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.
12/2010Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.
10/2010The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease.
8/2010Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
6/2010Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease.
4/2010Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
2/2010A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.
1/2010Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
1/2010Switching from oral donepezil to rivastigmine transdermal patch in Alzheimer's disease: 20-week extension phase results.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason T Olin Research Topics

Disease

20Alzheimer Disease (Alzheimer's Disease)
04/2011 - 05/2006
5Onychomycosis (Tinea Unguium)
11/2014 - 02/2013
4Parkinson Disease (Parkinson's Disease)
12/2010 - 01/2010
4Dementia (Dementias)
12/2010 - 01/2010
2Tinea Pedis (Athlete's Foot)
01/2015 - 07/2014
1Infections
11/2014
1Mycoses (Diseases, Fungus)
07/2014
1Nausea
04/2010
1Vomiting
04/2010

Drug/Important Bio-Agent (IBA)

14Rivastigmine (Exelon)FDA LinkGeneric
04/2011 - 06/2007
8Memantine (Namenda)FDA Link
04/2010 - 05/2006
6Donepezil (Aricept)FDA LinkGeneric
01/2010 - 05/2006
5efinaconazoleIBA
11/2014 - 02/2013
5SolutionsIBA
11/2014 - 02/2013
4Cholinesterase Inhibitors (Anticholinesterases)IBA
08/2010 - 10/2006
3TriazolesIBA
09/2014 - 02/2013
3Capsules (Microcapsules)IBA
04/2010 - 01/2010
2luliconazoleIBA
01/2015 - 07/2014
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2006 - 08/2006
1Antifungal AgentsIBA
09/2014
1A-factor (Streptomyces)IBA
01/2010
1TabletsIBA
06/2009
1sabeluzoleIBA
06/2007
1Galantamine (Galanthamine)FDA LinkGeneric
06/2007
1Nootropic Agents (Nootropics)IBA
06/2007

Therapy/Procedure

10Activities of Daily Living (ADL)
04/2011 - 05/2006
7Transdermal Patch
04/2011 - 06/2009
2Therapeutics
07/2014 - 08/2010